Frank W. Cawood 13D and 13G filings for Barinthus Biotherapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-11 6:43 pm Purchase | 2024-12-31 | 13G | BARINTHUS BIOTHERAPEUTICS PLC BRNS | Frank W. Cawood | 3,384,513 8.400% | 1,041,743 (+44.47%) | Filing |
| 2024-10-15 11:07 am Purchase | 2024-10-07 | 13G | BARINTHUS BIOTHERAPEUTICS PLC BRNS | Frank W. Cawood | 2,342,770 5.900% | 2,342,770 (New Position) | Filing |